Type 2 & other diabetes

Assessment of seven insulin resistance surrogate indexes for predicting cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

All seven insulin resistance surrogate indexes independently demonstrated elevated CMM risk. In the context of Chinese middle-aged and elderly cohorts, eGDR demonstrated a notable predictive capacity for CMM. ROC-derived cut-offs (eGDR < 7.64) are utilised for identifying high-risk individuals requiring intervention. Spline-derived thresholds (eGDR = 11.82) serve as therapeutic targets for risk reduction.

Study context

Population
Chinese participants aged ≥ 45 years, China Health and Retirement Longitudinal Study (CHARLS) 2011–2020
Participants
7,197 participants
Exposure
Seven IR surrogate indexes for predicting cardiometabolic multimorbidity (CMM)
Outcome
Incident cardiometabolic multimorbidity (CMM)
Follow-up
Median 9 years
Methodological detailsnational, CHARLS 2011-2020
  • National
  • CHARLS 2011-2020

Main finding

As reported in the abstract

Incident CMM

Developed CMM

1043

14.49%

Estimated glucose disposal rate (eGDR), per SD increase: adjusted HR

0.834 (0.781-0.891) (95% CI)

Observational data: associations, not effects.

Further findings

Nonlinearity (restricted cubic splines (RCS))

TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), Metabolic score for IR (METS-IR) and eGDR nonlinearly associated with incident CMM
P-nonlinearity < 0.05
eGDR L-shaped; CMM risk decreasing until inflection point 11.82, HR
0.758 (0.702-0.818) (95% CI)
TyG-WC U-shaped, inflection point
572.14

Predictive discrimination (time-dependent AUC)

eGDR superior predictive discrimination during early follow-up and across all intervals, AUC
0.68-0.76
Optimal eGDR cut-off
7.64

Original publication

Assessment of seven insulin resistance surrogate indexes for predicting cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study. Cardiovasc Diabetol. Published 5 April 2026. doi:10.1186/s12933-026-03168-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.